hydralazine and nephrin

hydralazine has been researched along with nephrin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azegami, T; Hayashi, K; Itoh, H; Sasamura, H	1
Hara, T; Hayden, MR; Hitomi, H; Ichimura, A; Ito, S; Kaifu, K; Kawachi, H; Kiyomoto, H; Kobori, H; Kohno, M; Matsumoto, S; Nishijima, Y; Nishiyama, A; Ohsaki, H; Sofue, T; Sowers, JR; Urushihara, M; Whaley-Connell, A	1

Other Studies

2 other study(ies) available for hydralazine and nephrin

Article	Year
Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy. Hypertension research : official journal of the Japanese Society of Hypertension, 2012, Volume: 35, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Enzyme Inhibitors; Hydralazine; Kidney Diseases; Kidney Glomerulus; Male; Membrane Proteins; NG-Nitroarginine Methyl Ester; Proteinuria; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Tetrazoles; Vaccines	2012
Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats. American journal of hypertension, 2012, Volume: 25, Issue:5 Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Hydralazine; Hydrochlorothiazide; Imidazoles; Juxtaglomerular Apparatus; Male; Membrane Proteins; Podocytes; Rats; Rats, Inbred OLETF; Reserpine; Tetrazoles	2012

Article

Year

Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy.

Hypertension research : official journal of the Japanese Society of Hypertension, 2012, Volume: 35, Issue:5

Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Enzyme Inhibitors; Hydralazine; Kidney Diseases; Kidney Glomerulus; Male; Membrane Proteins; NG-Nitroarginine Methyl Ester; Proteinuria; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Tetrazoles; Vaccines

2012

Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats.

American journal of hypertension, 2012, Volume: 25, Issue:5

Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Hydralazine; Hydrochlorothiazide; Imidazoles; Juxtaglomerular Apparatus; Male; Membrane Proteins; Podocytes; Rats; Rats, Inbred OLETF; Reserpine; Tetrazoles

2012